表紙
市場調査レポート

舞踏病:世界の治験レビュー

Chorea Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 306650
出版日 ページ情報 英文 52 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
舞踏病:世界の治験レビュー Chorea Global Clinical Trials Review, H1, 2014
出版日: 2014年05月30日 ページ情報: 英文 52 Pages
概要

当レポートでは、舞踏病に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

目次

イントロダクション

  • 舞踏病
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数

G7諸国における治験件数:中枢神経系治験に対する舞踏病治験件数比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

治験件数:フェーズ(相)別

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Auspex Pharmaceuticals, Inc.
    • Prestwick Pharmaceuticals, Inc.
    • Novartis AG
  • 代表的な研究機関病院の治験の概要
    • National Institute of Neurological Disorders and Stroke
    • The University of Iowa
    • 東北大学大学院医学系研究科・医学部
    • The Sheba Medical Center
    • University of Cape Town
    • National Heart, Lung, and Blood Institute

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2197CTIDB

GlobalData's clinical trial report, "Chorea Global Clinical Trials Review, H1, 2014" provides data on the Chorea clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chorea. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Chorea. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Chorea
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Chorea to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Chorea
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Chorea Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Auspex Pharmaceuticals, Inc.
      • Clinical Trial Overview of Auspex Pharmaceuticals, Inc.
      • Prestwick Pharmaceuticals, Inc.
      • Clinical Trial Overview of Prestwick Pharmaceuticals, Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
    • Clinical Trial Overview of Top Institutes / Government
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • The University of Iowa
      • Clinical Trial Overview of The University of Iowa
      • Tohoku University School of Medicine
      • Clinical Trial Overview of Tohoku University School of Medicine
      • The Sheba Medical Center
      • Clinical Trial Overview of The Sheba Medical Center
      • University of Cape Town
      • Clinical Trial Overview of University of Cape Town
      • National Heart, Lung, and Blood Institute
      • Clinical Trial Overview of National Heart, Lung, and Blood Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Chorea Therapeutics, Global, Clinical Trials by Region, 2014*
  • Chorea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chorea Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Chorea Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Chorea Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Chorea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Chorea to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chorea Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Chorea Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chorea Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chorea Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chorea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by Auspex Pharmaceuticals, Inc., 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by Prestwick Pharmaceuticals, Inc., 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Iowa, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University School of Medicine, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by The Sheba Medical Center, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cape Town, 2014*
  • Chorea Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014*

List of Figures

  • Chorea Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Chorea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Chorea Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Chorea Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Chorea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Proportion of Chorea to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Chorea Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Chorea Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Chorea Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Chorea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Chorea Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Chorea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top